What is Osteogenesis Imperfecta (OI)?
Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by increased bone fragility and recurrent fractures, primarily caused by defects in type I collagen production or structure. 1
Genetic Basis
OI has an estimated prevalence of 1 in 10,000 to 20,000 births, though genomic sequencing suggests it may be more common than previously recognized 1. The genetic architecture includes:
Autosomal Dominant Forms (∼90% of cases)
Type I OI (mildest): Caused by COL1A1 or COL1A2 haploinsufficiency, resulting in reduced quantity but structurally normal type I collagen. Presents as nondeforming OI with characteristic blue sclera 1
Type III OI (severe): Results from missense variants affecting glycine residues in collagen's triple helical domains, causing dominant negative effects. Presents as progressively deforming OI with severe bone deformities 1
Type IV OI (moderate): Similar glycine-affecting mutations as Type III but with variable severity, presenting as common variable OI with normal sclera and mild-to-moderate limb deformity 1
Autosomal Recessive Forms (less common)
Result from pathogenic variants in genes encoding proteins involved in collagen folding, posttranslational modification, bone mineralization, or osteoblast function 1, 2
Clinical Manifestations
Skeletal Features
The hallmark is increased skeletal fragility with lifelong elevated fracture risk 1. Key patterns include:
- Childhood: Highest fracture rates, particularly long-bone fractures 1
- Midlife: Fracture risk decreases but remains 6-fold higher than general population 1
- Older adulthood: Fracture rates rise sharply, with postmenopausal women showing 8-fold increased risk (95% CI: 5.6-11.4) 1
- Women: Additional elevated risk during pregnancy and postpartum 1
Additional skeletal manifestations include bone deformities (especially bowed femurs in moderate-to-severe OI), short stature, and kyphoscoliosis 1
Multisystem Involvement
Because type I collagen is present throughout connective tissues, OI affects multiple organ systems 1, 3:
- Dental: Dentinogenesis imperfecta
- Auditory: Hearing loss (progressive)
- Ocular: Blue sclera (Type I), ocular complications
- Cardiovascular: Cardiac valvular lesions
- Pulmonary: Respiratory complications
- Musculoskeletal: Joint hypermobility, muscle weakness
Pathophysiology
The skeletal fragility in OI is multifactorial 1:
- Reduced biomechanical properties of bone matrix
- Decreased bone mass and bone size
- Defective bone microarchitecture
- Abnormal bone remodeling with increased turnover and resorption
- Long-bone deformities that increase mechanical forces on bones
Clinical Variability
A critical pitfall: Clinical expression is highly variable even among individuals with identical collagen mutations, causing significant phenotypic variation within families sharing the same mutation 1. This heterogeneity ranges from mild bone fragility to severe forms with numerous fractures, profound deformities, and physical disabilities 1.
Mortality Impact
Life expectancy is reduced by approximately 9.5 years in men and 7.1 years in women compared to the general population 4. Leading causes of death include OI-related complications, cardiovascular and respiratory issues, and fracture-related trauma 4.
Essential Clinical Approach
Multidisciplinary care is mandatory for comprehensive management 1, 5. The progressive, heterogeneous nature of symptoms across the lifespan—with some manifestations (scoliosis, bone deformities) progressing rapidly in childhood while others (cardiac, ocular, auditory, joint issues) emerge in adulthood—necessitates coordinated input from physicians, orthopedic surgeons, physical therapists, occupational therapists, and other specialists 1, 4, 5.